New York, other states urge FDA to expand access to abortion pill


New York, other states urge FDA to expand access to abortion pill

Play all audios:


Newsletters ePaper Sign in HomeIndiaKarnatakaOpinionWorldBusinessSportsVideoEntertainmentDH SpecialsOperation SindoorNews ShotsExplainersBengaluruTrendingPhotosDH BrandspotHomeNews


ShotsTrendingMenu×ADVERTISEMENT ADVERTISEMENT ADVERTISEMENTHomeworldNew York, other states urge FDA to expand access to abortion pillMifepristone, together with the drug misoprostol, won FDA


approval in 2000 for medication abortion in the first 10 weeks of pregnancy.ReutersLast Updated : 05 June 2025, 13:41 IST Follow Us :


CommentsADVERTISEMENTPublished 05 June 2025, 13:41 ISTWorld newsNew YorkCaliforniaFDANew JerseyAbortionFollow us on : Follow Us IndiaSouthNorthWestEast & North EastOperation


SindoorOpinionEditorialSpeak OutCartoonKarnatakaBengaluruSportsCricketIPL 2025FootballEntertainmentMovie ReviewsPhotosTechnologyWorldSpecialsDH on SundayDH on SaturdaySign up for


NewslettersAll NewslettersTop News of the DayPolitical TheatreDH SportsletterExplainersExplained | Chenab bridge: How project team navigated through steep slopes on horses, mulesExplained |


The Epstein files obsessionExplained | From bros to foes: How the unlikely Trump-Musk relationship implodedThree major lapses: No coordination, no communication, no crowd managementWhat's


BrewingColombian senator Uribe fighting for life after shootingTiger, dog trapped in pit near Kerala-Tamil Nadu border, rescue under wayWon't apologise for standing up for patient denied


care: Goa ministerMeat pieces found near gym in Mathura, locals suspect cow slaughterLatest NewsColombian senator Uribe fighting for life after shootingBadshah addresses backlash over his


Dua Lipa comment, calls it 'most beautiful compliment'Congress says 'insensitivity' of PM Modi to suffering of people of Manipur 'truly shocking''Fish prasadam' distributed to asthma


patients in HyderabadThe Printers Mysore LtdPrajavaniSudhaMayuraEpaperClassifiedsContactAboutPrivacy PolicyTermsDisclaimerGrievance Redressal